Home » Topics » Regulatory » Patents

Patents
RSS

Humanized CD38 antibodies for cancer/autoimmune disease treatment

July 26, 1996

Biogal describes cyclosporin emulsions

July 26, 1996

Rapamycin esters from American Home Products

July 26, 1996

Immunoregulatory peptides with special binding properties

July 26, 1996

HSV proteins as immune resonse regulators

July 26, 1996

Erythropoietin claimed as chronic inflammation treatment

July 26, 1996

Matrix metalloproteinase inhibitors described by British Biotech

July 26, 1996

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

Xoma claims rBPI21 + antibiotic combination for Gram-negative infections

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...